[1] |
TOWNSEND N, WILSON L, BHATNAGAR P, et al. Cardiovascular disease in Europe: epidemiological update 2016[J]. Eur Heart J, 2016, 37(42): 3232-3245. doi: 10.1093/eurheartj/ehw334
|
[2] |
北京高血压防治协会, 北京糖尿病防治协会, 北京慢性病防治与健康教育研究会, 等. 基层心血管病综合管理实践指南2020[J]. 中国医学前沿杂志(电子版), 2020, 12(8): 1-73. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY202008002.htm
|
[3] |
胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3): 209-220. doi: 10.3969/j.issn.1000-3614.2019.03.001
|
[4] |
ORMAZABAL V, NAIR S, ELFEKY O, et al. Association between insulin resistance and the development of cardiovascular disease[J]. Cardiovasc Diabetol, 2018, 17(1): 122. doi: 10.1186/s12933-018-0762-4
|
[5] |
DI PINO A, DEFRONZO R A. Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents[J]. Endocr Rev, 2019, 40(6): 1447-1467. doi: 10.1210/er.2018-00141
|
[6] |
ADEVA-ANDANY M M, AMENEIROS-RODRÍGUEZ E, FERNÁNDEZ-FERNÁNDEZ C, et al. Insulin resistance is associated with subclinical vascular disease in humans[J]. World J Diabetes, 2019, 10(2): 63-77. doi: 10.4239/wjd.v10.i2.63
|
[7] |
HARI KUMAR K V S. The good, the bad, and the ugly facets of insulin resistance[J]. Med J Armed Forces India, 2020, 76(1): 4-7. doi: 10.1016/j.mjafi.2019.07.001
|
[8] |
AKOUMIANAKIS I, ANTONIADES C. Impaired vascular redox signaling in the vascular complications of obesity and diabetes mellitus[J]. Antioxid Redox Signal, 2019, 30(3): 333-353. doi: 10.1089/ars.2017.7421
|
[9] |
CHEN W, WANG S, LV W, et al. Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e001217. doi: 10.1136/bmjdrc-2020-001217
|
[10] |
DEFRONZO R A, TOBIN J D, ANDRES R. Glucose clamp technique: a method for quantifying insulin secretion and resistance[J]. Am J Physiol, 1979, 237(3): E214-E223. http://pdfs.semanticscholar.org/b451/a01e4fd7b523374eaa94de032e2d1f5574ed.pdf
|
[11] |
MATTHEWS D R, HOSKER J P, RUDENSKI A S, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28(7): 412-419. doi: 10.1007/BF00280883
|
[12] |
SO A, SAKAGUCHI K, OKADA Y, et al. Relation between HOMA-IR and insulin sensitivity index determined by hyperinsulinemic-euglycemic clamp analysis during treatment with a sodium-glucose cotransporter 2 inhibitor[J]. Endocr J, 2020, 67(5): 501-507. doi: 10.1507/endocrj.EJ19-0445
|
[13] |
MOHD NOR N S, LEE S, BACHA F, et al. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp[J]. Pediatr Diabetes, 2016, 17(6): 458-465. doi: 10.1111/pedi.12303
|
[14] |
CHAMROONKIADTIKUN P, ANANCHAISARP T, WANICHANON W. The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study[J]. Prim Care Diabetes, 2020, 14(2): 161-167. doi: 10.1016/j.pcd.2019.08.004
|
[15] |
GUERRERO-ROMERO F, VILLALOBOS-MOLINA R, JIMÉNEZ-FLORES J R, et al. Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults[J]. Arch Med Res, 2016, 47(5): 382-387. doi: 10.1016/j.arcmed.2016.08.012
|
[16] |
NAVARRO-GONZÁLEZ D, SÁNCHEZ-ÍÑIGO L, PASTRANA-DELGADO J, et al. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort[J]. Prev Med, 2016, 86: 99-105. doi: 10.1016/j.ypmed.2016.01.022
|
[17] |
LOW S, KHOO K C J, IRWAN B, et al. The role of triglyceride glucose index in development of Type 2 diabetes mellitus[J]. Diabetes Res Clin Pract, 2018, 143: 43-49. doi: 10.1016/j.diabres.2018.06.006
|
[18] |
LEE D Y, LEE E S, KIM J H, et al. Predictive value of triglyceride glucose index for the risk of incident diabetes: A 4-Year retrospective longitudinal study[J]. PLoS One, 2016, 11(9): e0163465. doi: 10.1371/journal.pone.0163465
|
[19] |
ZHANG M, WANG B, LIU Y, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study[J]. Cardiovasc Diabetol, 2017, 16(1): 30. doi: 10.1186/s12933-017-0514-x
|
[20] |
LAMBRINOUDAKI I, KAZANI M V, ARMENI E, et al. The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women[J]. Heart Lung Circ, 2018, 27(6): 716-724. doi: 10.1016/j.hlc.2017.05.142
|
[21] |
LEE S B, AHN C W, LEE B K, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults[J]. Cardiovasc Diabetol, 2018, 17(1): 41. doi: 10.1186/s12933-018-0692-1
|
[22] |
殷为勇, 王香云, 肖美娟, 等. 甘油三酯葡萄糖指数与颅内动脉粥样硬化性狭窄的研究[J]. 中国现代医生, 2016, 54(4): 12-14, 18. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201604005.htm
|
[23] |
SÁNCHEZ-ÍÑIGO L, NAVARRO-GONZÁLEZ D, FERNÁNDEZ-MONTERO A, et al. The TyG index may predict the development of cardiovascular events[J]. Eur J Clin Invest, 2016, 46(2): 189-197. doi: 10.1111/eci.12583
|
[24] |
REARDON C A, LINGARAJU A, SCHOENFELT K Q, et al. Obesity and insulin resistance promote atherosclerosis through an IFNgamma-Regulated macrophage protein network[J]. Cell Rep, 2018, 23(10): 3021-3030. doi: 10.1016/j.celrep.2018.05.010
|
[25] |
WON K B, KIM Y S, LEE B K, et al. The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics[J]. Medicine(Baltimore), 2018, 97(21): e10726. http://www.onacademic.com/detail/journal_1000040459176610_8ed1.html
|
[26] |
KIM M K, AHN C W, KANG S, et al. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults[J]. Cardiovasc Diabetol, 2017, 16(1): 108. doi: 10.1186/s12933-017-0589-4
|
[27] |
PARK K, AHN C W, LEE S B, et al. Elevated TyG index predicts progression of coronary artery calcification[J]. Diabetes Care, 2019, 42(8): 1569-1573. doi: 10.2337/dc18-1920
|
[28] |
F PIEPOLI M. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)[J]. Int J Behav Med, 2017, 24(3): 321-419. doi: 10.1007/s12529-016-9583-6
|
[29] |
PARK G M, CHO Y R, WON K B, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors[J]. Lipids Health Dis, 2020, 19(1): 7. doi: 10.1186/s12944-020-1187-0
|
[30] |
LI S, GUO B, CHEN H, et al. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis[J]. Sci Rep, 2019, 9(1): 7320. doi: 10.1038/s41598-019-43776-5
|
[31] |
MAO Q, ZHOU D, LI Y, et al. The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome[J]. Dis Markers, 2019, 2019: 6891537. http://www.ncbi.nlm.nih.gov/pubmed/31281548
|
[32] |
JIN J L, SUN D, CAO Y X, et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study[J]. Ann Med, 2018, 50(7): 576-586. doi: 10.1080/07853890.2018.1523549
|
[33] |
MA X, DONG L, SHAO Q, et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome[J]. Cardiovasc Diabetol, 2020, 19(1): 31. doi: 10.1186/s12933-020-01006-7
|
[34] |
LUO E, WANG D, YAN G, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention[J]. Cardiovasc Diabetol, 2019, 18(1): 150. doi: 10.1186/s12933-019-0957-3
|
[35] |
DA SILVA A A, DO CARMO J M, LI X, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited[J]. Can J Cardiol, 2020, 36(5): 671-682. doi: 10.1016/j.cjca.2020.02.066
|
[36] |
ZAMORA M, VILLENA J A. Contribution of impaired insulin signaling to the pathogenesis of diabetic cardiomyopathy[J]. Int J Mol Sci, 2019, 20(11): 2833. doi: 10.3390/ijms20112833
|
[37] |
KAUR R, KAUR M, SINGH J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies[J]. Cardiovasc Diabetol, 2018, 17(1): 121. doi: 10.1186/s12933-018-0763-3
|
[38] |
GAIZ A, MOSAWY S, COLSON N, et al. Thrombotic and cardiovascular risks in type two diabetes; Role of platelet hyperactivity[J]. Biomed Pharmacother, 2017, 94: 679-686. doi: 10.1016/j.biopha.2017.07.121
|
[39] |
REAVEN G M, KNOWLES J W, LEONARD D, et al. Relationship between simple markers of insulin resistance and coronary artery calcification[J]. J Clin Lipidol, 2017, 11(4): 1007-1012. doi: 10.1016/j.jacl.2017.05.013
|
[40] |
SÁNCHEZ-GARCÍA A, RODRÍGUEZ-GUTIÉRREZ R, MANCILLAS-ADAME L, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review[J]. Int J Endocrinol, 2020, 2020: 4678526. http://www.researchgate.net/publication/339842433_Diagnostic_Accuracy_of_the_Triglyceride_and_Glucose_Index_for_Insulin_Resistance_A_Systematic_Review
|